Evaluating Placental Alkaline Phosphatase as a Serum Marker in Testicular Cancer
Author Information
Author(s): D.F. Tucker, R.T.D. Oliver, P. Travers, W.F. Bodmer
Primary Institution: Imperial Cancer Research Fund and Institute of Urology, London, UK
Hypothesis
Can placental-like alkaline phosphatase (PLAP) serve as a reliable serum marker for testicular germ cell tumors?
Conclusion
The study suggests that measuring PLAP levels can be useful in managing patients with germ cell tumors, especially seminoma.
Supporting Evidence
- 88% of seminoma patients had elevated serum PLAP levels.
- 54% of patients with mixed seminoma and malignant teratoma had elevated serum PLAP levels.
- 33% of patients with malignant teratoma had elevated serum PLAP levels.
- Smoking was associated with increased serum PLAP levels.
Takeaway
Doctors can check a special protein in the blood to help find and treat certain types of testicular cancer.
Methodology
The study used a solid-phase localization of enzyme activity assay to evaluate serum PLAP levels in patients and controls.
Potential Biases
Potential bias due to the influence of smoking on PLAP levels.
Limitations
The study's findings may be affected by smoking, which can produce false positive results.
Participant Demographics
Included 213 normal blood donors and 50 patients with established metastatic testicular germ cell tumors.
Statistical Information
P-Value
0.0001
Statistical Significance
p=0.0001
Want to read the original?
Access the complete publication on the publisher's website